Table 3

Comparison of 23 TAU CC lines with respect to control bone volume before infection (CBV), and residual bone volume (RBV) and loss of bone volume (LBV) following infection
Rank Line CBV RBV LBV
No. Mean* No. Mean* Mean*
CC01 CC026/TAU 4 10.68d,e 6 6.65c,d,e 4.03c,d***
CC02 CC030/TAU 8 7.05b,c 9 5.90b,c,d 1.15a,b,c,d
CC03 CC034/TAU 10 3.45 a 4 3.45a,b 0a,b
CC04 CC057/TAU 3 11.10d,e 5 6.44c,d,e 4.66d***
CC05 CC072/TAU 12 6.28a,b 11 4.72a,b,c 1.56a,b,c,d***
CC06 CC111/TAU 8 6.34a,b 6 5.80b,c,d 0.54a,b,c
CC07 CC114/TAU 5 7.98b,c 6 10.12e,f −2.14a
CC08 CC182/TAU 5 10.70d,e 5 6.02c,d 4.68d***
CC09 CC188/TAU 5 5.44 a 5 5.54b,c,d −0.10a,b
CC10 CC196/TAU 8 8.19b,c,d 8 6.13c,d 2.06b,c,d***
CC11 CC211/TAU 4 5.88a,b 6 5.50b,c 0.38a,b,c
CC12 CC219/TAU 5 5.62a,b 5 4.46a,b 1.16a,b,c,d
CC13 CC521/TAU 7 5.89a,b 5 5.50b,c 0.39a,b,c
CC14 CC530/TAU 4 5.58a,b 3 6.03c,d −0.45a,b
CC15 CC534/TAU 3 6.0a,b 4 5.55b,c,d 0.45a,b,c
CC16 CC551/TAU 6 3.72a 7 2.64a 1.08a,b,c,d
CC17 CC611/TAU 4 5.83a,b 6 4.90a,b,c 0.93a,b,c,d
CC18 CC643/TAU 5 6.08a,b 3 6.07c,d 0.01a,b
CC19 CC670/TAU 6 9.93c,d,e 4 8.53e,f 1.40a,b,c,d
CC20 CC688/TAU 3 3.70a 5 4.54a,b,c −0.84a,b
CC21 CC696/TAU 6 8.30b,c,d,e 4 8.20d,e 0.10a,b
CC22 CC711/TAU 13 6.29a,b 10 4.8a,b,c 1.49a,b,c,d**
CC23 CC785/TAU 5 6.50a,b 6 5.17a,b,c 1.33a,b,c,d
Mean/Total SD 139 6.80 133 5.77 1.13
2.17 1.59 1.63

CBV Control Bone Volume.

RBV Residual Bone Volume.

LBV Loss of Bone volume.

No. number of mice.

* = × 10-3mm3.

** = P <0.01.

*** = P <0.001.

a,b,c,d,e,f = Lines within a column that share the same superscript letter do not differ significantly by Duncan’s Least Significant Range test.

Shusterman et al.

Shusterman et al. BMC Genetics 2013 14:68   doi:10.1186/1471-2156-14-68

Open Data